Last reviewed · How we verify

NCT03420157: APACHE-4/FG

Carrying Out of Focus Group to Improve Cervical Screening Proposal by Vaginal Self-sampling (APACHE-4/FG).

Completed Last updated 18 July 2019
What this trial tests

trial testing Focus Group in Cancer Cervix in 20 participants. Completed in 8 February 2018.

Timeline
24 January 2018
Primary endpoint
8 February 2018
8 February 2018

Quick facts

Lead sponsorUniversity Hospital, Tours
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date24 January 2018
Primary completion8 February 2018
Estimated completion8 February 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Tours

Who can join

Adults 30 to 65, female only, with Cancer Cervix. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite the existence of an effective screening test (pap smear), cervical cancer is, every year in France, the cause of more than 3,000 new cases and 1,100 deaths. But, in France, 4 in 10 women are not screened or not often enough (nearly 7 millions women). It is therefore necessary to develop new strategies to reach these women. The etiological factor of this cancer is persistent infection with oncogenic High-Risk Human PapillomaVirus (HR-HPV). Thereby, HPV-based tests could be alternative screening tests. Vaginal self-sampling with HR-HPV test is simpler and less intrusive than the pap smear. It has been shown that vaginal self-sampling with HPV test is a powerful means to increase the participation rate in cervical cancer screening. The investigators hypothesize that it is possible to optimize participation rate by improving the communication media associated to the vaginal self-sampling kit. This is why the accompanying letter and the leaflet explaining how to perform the vaginal self-sampling will be submit to women opinion by using the Focus Group method. The objective is to identify improvement ideas of these two communication media.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Focus Group

Trials testing the same drug.

Other recruiting trials for Cancer Cervix

Currently open trials in the same condition.

Other University Hospital, Tours trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03420157.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing